Tag: GlaxoSmithKline
GSK, CureVac team up to develop and manufacture vaccine against COVID-19 mutants
UK-based GlaxoSmithKline announced today that it has partnered with German pharmaceutical company CureVac to jointly develop next-generation mRNA vaccines for emerging COVID-19 variants.
The €150m...
GSK to close its manufacturing facility in Sydney, 223 jobs to go
Pharmaceutical company GlaxoSmithKline (GSK) will shut down its manufacturing facility at Ermington, in Sydney’s north-west, in 2020.
GSK said the decision to close down the...
GSK: Sydney Factory is not closing
Global pharmaceutical giant GlaxoSmithKline (GSK) has denied that it plans to shut down its Sydney factory despite recent outsourcing of Victorian jobs to Spain...
Novartis, GSK shake up pharmaceutical industry with major deals
Pharmaceutical giant Novartis and global healthcare company GlaxoSmithKline (GSK) have announced a series of transactions worth billions of dollars that will transform both firms'...
National Association of Women in Operations hosts Girls Experience Industry Days
Leading global companies, which are members of the National Association of Women in Operations (NAWO) gave high-school girls and pre-career girls an opportunity to...
Featured Article
Navigating energy price volatility with predictive intelligence
Energy price volatility has become a structural feature of modern electricity markets rather than a temporary disruption. For energy-intensive manufacturers and large commercial operators, fluctuating wholesale prices are reshaping how energy costs are managed, making reactive approaches increasingly inadequate.
